Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, and non-destructive behavior, and the description adds rich behavioral detail: ambiguous matches return figi_candidates rather than assertions, unresolved identifiers remain visible under unresolved, enrichment degrades gracefully, and calls cascade through multiple internal endpoints. No statement contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The definition is front-loaded: purpose and usage rule appear immediately, followed by structured type-by-type detail. It is long and dense, forming a wall of text in places, but nearly every clause carries useful behavioral or semantic information rather than padding.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a multi-source resolver with no output schema, the description explains what the agent should expect: CIK, ticker, company_name, LEI, FIGI, RxCUI, figi_candidates, unresolved, source labels, and a citation URI. It also covers failure modes and graceful degradation, so the agent can set expectations even without an output schema.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema has 100% parameter coverage, the description adds substantial meaning: it reveals that company inputs may also be ISINs, which the schema omits, and it warns to pass the issuer exactly as printed rather than the full noun phrase. It also gives concrete examples for both company and drug values, materially reducing misuse.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language queries and clearly states the deliverable: resolving a user-spoken name to canonical/official identifiers needed by other tools. It also distinguishes itself from siblings by positioning itself as the first-step ID resolver (Use FIRST...), and enumerates exact outputs such as CIK, LEI, FIGI, and RxCUI.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: Use FIRST whenever you have a name but need an ID, and it documents accepted inputs for both company and drug lookups. However, it never names sibling tools like entity_profile or compare_entities or states when to prefer them, so it provides strong context without explicit exclusions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

There are several near-duplicate clusters: ask_pipeworx, ask_pipeworx_beta (explicitly described as currently identical), ask_pipeworx_grounded, deep_research, and validate_claim all route to the same underlying data; the six Polymarket tools (bet_research, arbitrage, edges, edge_tracker, fill_risk, kalshi_spread) heavily overlap in purpose and are easy to confuse. Even detailed descriptions do not fully resolve which tool an agent should pick first.

Naming Consistency3/5

All names use snake_case and many follow a verb_noun pattern (search_filings, get_filing, list_issue_codes, resolve_entity), but there is a mix of verb-first names (ask_pipeworx, compare_entities, generate_llms_txt), noun-first names (recent_changes, entity_profile, pipeworx_trending), and brand-prefixed families (pipeworx_*, polymarket_*). The naming is readable but not a single predictable pattern.

Tool Count2/5

A server named 'Senate Lobbying' exposes 34 tools, but only three (search_filings, get_filing, list_issue_codes) relate to LDA lobbying data. The remaining 31 cover generic Pipeworx data lookup, prediction markets, memory, subscriptions, AI visibility, and npm package audits—an extreme overreach for the apparent scope and likely to confuse an agent expecting a focused lobbying toolkit.

Completeness2/5

For the lobbying domain implied by the server name, only search, get-one-filing, and issue-code enumeration exist; there is no aggregation/stats tool, no lobbyist/client entity resolution for LDA, no registrant or foreign-entity browsing, and no coverage of related concepts like lobbying firm hierarchies or spending trends. The generic Pipeworx tools fill a different domain, so the lobbying-specific surface has significant gaps.